首页> 美国卫生研究院文献>Self Nonself >Co-inhibitory molecules
【2h】

Co-inhibitory molecules

机译:共抑制分子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nearly forty years ago the concept was proposed that lymphocytes are negatively regulated by what are now called co-inhibitory signals. Nevertheless, it is only the more recent identification of numerous co-inhibitors and their critical functions that has brought co-inhibition to the forefront of immunologic research. Although co-inhibitory signals have been considered to directly regulate conventional T cells, more recent data has indicated a convergence between co-inhibitory signals and the other major negative control mechanism in the periphery that is mediated by regulatory T cells. Furthermore, it is now clear that lymphocytes are not the sole domain of co-inhibitory signals, as cells of the innate immune system, themselves controllers of immunity, are regulated by co-inhibitors they express. Thus, in order to better understand negative regulation in the periphery and apply this knowledge to the treatment of disease, a major focus for the future should be the definition of the conditions where co-inhibition controls effector cells intrinsically versus extrinsically (via regulatory or innate cells).
机译:大约四十年前,有人提出淋巴细胞受现在称为共抑制信号负调节的概念。然而,只有最近对多种共抑制剂及其关键功能的鉴定才将共抑制剂带入了免疫学研究的前沿。尽管共抑制信号已被认为可以直接调节常规T细胞,但最近的数据表明,共抑制信号与周围的其他主要负控制机制之间的融合是由调节T细胞介导的。而且,现在清楚的是,淋巴细胞不是共抑制信号的唯一域,因为先天免疫系统的细胞本身就是免疫的控制者,它们受到它们表达的共抑制剂的调节。因此,为了更好地理解周围环境的负调控并将这种知识应用于疾病的治疗,未来的主要重点应该是确定共抑制条件是内源性还是外源性(通过调控或先天性)共同控制效应细胞的条件。细胞)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号